SEC INSIDER TRANSACTIONS

EQUIFAX INC (EFX) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

EFX · EQUIFAX INC

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 4 filings · fetched 2026-11-13T17:38:45Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page

6sale rows on this page

9matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-09Filed 2026-11-12	Farshchi JamilOfficer · EVP, Chief Technology Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/11/2026. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 510 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	15,110D	189.77	Direct	Form 4 ↗0001225208-26-008885
2026-10-30Filed 2026-11-02	Schneider HaraldOfficer · EVP, Chief D&A Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. References: F1	F WithholdingCommon Stock · Non-derivative	689D	184.6	Direct	Form 4 ↗0001225208-26-008580
2026-10-29Filed 2026-11-02	GAMBLE JOHN W JROfficer · EVP, CFO & COO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/28/2026. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	4,000D	177.68	Direct	Form 4 ↗0001225208-26-008579
2026-10-23Filed 2026-10-27	Begor Mark WDirector · Officer · CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $186.6698 to $187.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $184.9466 to $185.5977, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $181.7387 to $182.6225, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The option vested in three equal annual increments beginning 5/4/2019. References: F1, F6	M Exercise / conversionStock Option/Right to Buy · Derivative	37,792D	0	Direct	Form 4 ↗0001225208-26-008522
2026-10-23Filed 2026-10-27	Begor Mark WDirector · Officer · CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $186.6698 to $187.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $184.9466 to $185.5977, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $181.7387 to $182.6225, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The option vested in three equal annual increments beginning 5/4/2019. References: F1, F5, F2	S Sale (market/private)Common Stock · Non-derivative	33,667D	182.517	Direct	Form 4 ↗0001225208-26-008522
2026-10-23Filed 2026-10-27	Begor Mark WDirector · Officer · CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $186.6698 to $187.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $184.9466 to $185.5977, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $181.7387 to $182.6225, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The option vested in three equal annual increments beginning 5/4/2019. References: F1, F4, F2	S Sale (market/private)Common Stock · Non-derivative	1,681D	185.2034	Direct	Form 4 ↗0001225208-26-008522
2026-10-23Filed 2026-10-27	Begor Mark WDirector · Officer · CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $186.6698 to $187.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $184.9466 to $185.5977, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $181.7387 to $182.6225, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The option vested in three equal annual increments beginning 5/4/2019. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	1,250D	183.403	Direct	Form 4 ↗0001225208-26-008522
2026-10-23Filed 2026-10-27	Begor Mark WDirector · Officer · CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $186.6698 to $187.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $184.9466 to $185.5977, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $181.7387 to $182.6225, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The option vested in three equal annual increments beginning 5/4/2019. References: F1, F3, F2	S Sale (market/private)Common Stock · Non-derivative	1,194D	186.7335	Direct	Form 4 ↗0001225208-26-008522
2026-10-23Filed 2026-10-27	Begor Mark WDirector · Officer · CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025. F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $186.6698 to $187.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $184.9466 to $185.5977, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $181.7387 to $182.6225, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F6 The option vested in three equal annual increments beginning 5/4/2019. References: F1, F2	M Exercise / conversionCommon Stock · Non-derivative	37,792A	112.46	Direct	Form 4 ↗0001225208-26-008522

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.